Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNaL, and Total Nicotine Equivalents.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Jacob (2020)
Minor Tobacco alkaloids as Biomarkers to Distinguish Combusted Tobacco Use From Electronic Nicotine Delivery Systems Use. Two New analytical Methods.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Jacob (2022)
Nicotine pharmacokinetics of electronic cigarettes: a pooled data analysis from the literature.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharamacokinetics
Jacobson (2021)
Firsthand and Secondhand Exposure Levels of Maltol-Flavored Electronic Nicotine Delivery System Vapors Disrupt amino acid Metabolism.
Individual Clinical
Respiratory Toxicity
Jarrell (2021)
Understanding potential mechanisms of harm: the drivers of electronic cigarette-induced changes in alveolar macrophages, neutrophils, and lung epithelial cells.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharamacokinetics
Jasper (2021)
Five-Day Changes in Biomarkers of Exposure among adult Smokers after Completely Switching From Combustible Cigarettes to a Nicotine-Salt Pod System.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Jay (2020)
Impact of vaping on respiratory health.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Jonas (2022)
Vaping-Related acute Parenchymal Lung Injury: a Systematic Review.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Jonas (2020)
a cross-category puffing topography, mouth level exposure and consumption study among Italian users of tobacco and nicotine products.
Individual Clinical
User Topography
Jones (2020)
E-cigarette use is associated with susceptibility to tobacco use among australian young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Jongenelis (2019)